CUSIP 45719W205COM NEWIKTQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
74 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Sands Capital Alternatives, LLC | 13.02M | $26.69M | +2.07M | Added |
| 2 | Soleus Capital Management, L.P. | 10.88M | $22.29M | +4.55M | Added |
| 3 | Fairmount Funds Management LLC | 8.63M | $17.68M | +2.50M | Added |
| 4 | Adar1 Capital Management, LLC | 8.06M | $16.53M |
| +2.82M |
| Added |
| 5 | Trails Edge Capital Partners, LP | 6.18M | $12.67M | +6.18M | New Position |
| 6 | Blackstone Inc. | 5.94M | $12.17M | +3.30M | Added |
| 7 | Siren, L.L.C. | 5.85M | $11.99M | +5.85M | New |
| 8 | Perceptive Advisors LLC | 5.42M | $11.11M | 0 | Held |
| 9 | Commodore Capital LP | 5.40M | $11.06M | 0 | Held |
| 10 | Vanguard Group Inc | 4.56M | $9.35M | +1.29M | Added |
See every fund holding Inhibikase Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders